Unknown

Dataset Information

0

3-Amido-3-aryl-piperidines: A Novel Class of Potent, Selective, and Orally Active GlyT1 Inhibitors.

ABSTRACT: 3-Amido-3-aryl-piperidines were discovered as a novel structural class of GlyT1 inhibitors. The structure-activity relationship, which was developed, led to the identification of highly potent compounds exhibiting excellent selectivity against the GlyT2 isoform, drug-like properties, and in vivo activity after oral administration.

SUBMITTER: Pinard E 

PROVIDER: S-EPMC4027785 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Identification of an Orally Bioavailable, Potent, and Selective Inhibitor of GlyT1.
| S-EPMC4007840 | biostudies-other
Unknown Novel 3-Oxazolidinedione-6-aryl-pyridinones as Potent, Selective, and Orally Active EP3 Receptor Antagonists.
| S-EPMC4007852 | biostudies-other
Unknown Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1.
| S-EPMC7957935 | biostudies-literature
Unknown Discovery of Novel 3,3-Disubstituted Piperidines as Orally Bioavailable, Potent, and Efficacious HDM2-p53 Inhibitors.
| S-EPMC4789661 | biostudies-literature
Unknown Fragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 Inhibitors.
| S-EPMC4025827 | biostudies-literature
Unknown Identification of Imidazo[1,2-b]pyridazine Derivatives as Potent, Selective, and Orally Active Tyk2 JH2 Inhibitors.
| S-EPMC6421589 | biostudies-literature
Unknown Discovery of CS-0777: A Potent, Selective, and Orally Active S1P1 Agonist.
| S-EPMC4017972 | biostudies-other
Proteomics Identification of potent and reversible piperidine carboxamides that are species-selective orally active proteasome inhibitors to treat malaria
2024-07-30 | PXD053252 | Pride
Proteomics Identification of potent and reversible piperidine carboxamides that are species-selective orally active proteasome inhibitors to treat malaria
2024-07-30 | PXD052762 | Pride
Proteomics Identification of potent and reversible piperidine carboxamides that are species-selective orally active proteasome inhibitors to treat malaria
2024-07-30 | PXD052830 | Pride